About N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide
N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide (PubChem CID 11421712) has the molecular formula C29H31F3N6O3
and a molecular weight of 568.60 g/mol. Its IUPAC name is N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide.
Molecular Properties
| Compound Name | N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| PubChem CID | 11421712 |
| Molecular Formula | C29H31F3N6O3 |
| Molecular Weight | 568.60 g/mol |
| Exact Mass | 568.24 |
| IUPAC Name | N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| SMILES | O=C(NCC(=O)N1CC[C@H](NC2CCC(O)(c3ccc(-c4cnccn4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1 |
| InChI | InChI=1S/C29H31F3N6O3/c30-29(31,32)21-3-1-2-19(14-21)27(40)36-17-26(39)38-13-8-23(18-38)37-22-6-9-28(41,10-7-22)25-5-4-20(15-35-25)24-16-33-11-12-34-24/h1-5,11-12,14-16,22-23,37,41H,6-10,13,17-18H2,(H,36,40)/t22?,23-,28?/m0/s1 |
| InChIKey | AYMVUOQELHPZJV-CBQRAPNFSA-N |
| XLogP | 3.31 |
| TPSA | 120.34 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 568.60 |
| LogP ≤ 5 | 3.31 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide?
The IUPAC name of N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide (CID 11421712) is N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide.
What is the SMILES notation for N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide?
The canonical SMILES for N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide is O=C(NCC(=O)N1CC[C@H](NC2CCC(O)(c3ccc(-c4cnccn4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1.
What is the InChIKey of N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide?
The InChIKey is AYMVUOQELHPZJV-CBQRAPNFSA-N. The full InChI is InChI=1S/C29H31F3N6O3/c30-29(31,32)21-3-1-2-19(14-21)27(40)36-17-26(39)38-13-8-23(18-38)37-22-6-9-28(41,10-7-22)25-5-4-20(15-35-25)24-16-33-11-12-34-24/h1-5,11-12,14-16,22-23,37,41H,6-10,13,17-18H2,(H,36,40)/t22?,23-,28?/m0/s1.
What are the key properties of N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide?
N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide has a molecular weight of 568.60 g/mol, XLogP of 3.31, 7 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrazin-2-yl-2-pyridinyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide is sourced from PubChem (CID 11421712), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).